Found: 14
Select item for more details and to access through your institution.
Correction to: CHD1L prevents lipopolysaccharide-induced hepatocellular carcinomar cell death by activating hnRNP A2/B1-nmMYLK axis.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
CHD1L prevents lipopolysaccharide-induced hepatocellular carcinomar cell death by activating hnRNP A2/B1-nmMYLK axis.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 10, p. 1, doi. 10.1038/s41419-021-04167-9
- By:
- Publication type:
- Article
CHD1L augments autophagy-mediated migration of hepatocellular carcinoma through targeting ZKSCAN3.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 10, p. 1, doi. 10.1038/s41419-021-04254-x
- By:
- Publication type:
- Article
CHD1L contributes to cisplatin resistance by upregulating the ABCB1–NF-κB axis in human non-small-cell lung cancer.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 2, p. 1, doi. 10.1038/s41419-019-1371-1
- By:
- Publication type:
- Article
CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17.
- Published in:
- Molecular Cancer, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12943-020-01184-8
- By:
- Publication type:
- Article
Molecular subclassification of gastrointestinal cancers based on cancer stem cell traits.
- Published in:
- Experimental Hematology & Oncology, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s40164-021-00246-x
- By:
- Publication type:
- Article
Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 579, p. 1, doi. 10.1126/scitranslmed.abb6282
- By:
- Publication type:
- Article
Identification of CHD1L as an Important Regulator for Spermatogonial Stem Cell Survival and Self-Renewal.
- Published in:
- Stem Cells International, 2016, p. 1, doi. 10.1155/2016/4069543
- By:
- Publication type:
- Article
Correction to: CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-27525-9
- By:
- Publication type:
- Article
N<sup>6</sup>-methyladenosine modification of circNSUN2 facilitates cytoplasmic export and stabilizes HMGA2 to promote colorectal liver metastasis.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-12651-2
- By:
- Publication type:
- Article
Increased expression of annexin I is associated with drug-resistance in nasopharyngeal carcinoma and other solid tumors.
- Published in:
- Proteomics - Clinical Applications, 2009, v. 3, n. 6, p. 654, doi. 10.1002/prca.200800164
- By:
- Publication type:
- Article
Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article